Results 151 to 160 of about 7,954 (256)

A phase 1b/2 study of intermittent talazoparib plus temozolomide in patients with metastatic castration-resistant prostate cancer and no mutations in DNA damage response genes. [PDF]

open access: yesInvest New Drugs
Autio KA   +11 more
europepmc   +1 more source

Open educational resources for distributed hands-on teaching in molecular biology. [PDF]

open access: yesPLoS One
Cerda A   +24 more
europepmc   +1 more source

Real-world clinical outcomes of sacituzumab govitecan after prior exposure to enfortumab vedotin in patients with metastatic urothelial carcinoma. [PDF]

open access: yesESMO Open
Sternschuss M   +17 more
europepmc   +1 more source

Squamous cell carcinoma of unknown primary (SCCUP): a genomic landscape study. [PDF]

open access: yesESMO Open
Robinson HR   +18 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy